Tags

Type your tag names separated by a space and hit enter

Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus.

Abstract

BACKGROUND

The risk of microalbuminuria in patients with insulin-dependent diabetes mellitus (IDDM) is thought to depend on the degree of hyperglycemia, but the relation between the degree of hyperglycemia and urinary albumin excretion has not been defined.

METHODS

We measured urinary albumin excretion in three random urine samples obtained at least one month apart from 1613 patients with IDDM. Microalbuminuria or overt albuminuria was considered to be present if the ratio of albumin (in micrograms) to creatinine (in milligrams) was 17 to 299 or > or = 300, respectively, for men and 25 to 299 or > or = 300, respectively, for women. Measurements of glycosylated hemoglobin (hemoglobin A1) obtained up to four years before the urine testing were used as an index of hyperglycemia. Twelve percent of the patients had overt albuminuria and were excluded from subsequent analyses.

RESULTS

The prevalence of microalbuminuria was 18 percent in patients with IDDM. It increased with increasing postpubertal duration of diabetes and, within each six-year interval of disease duration, it increased nonlinearly with the hemoglobin A1 value. For hemoglobin A1 values below 10.1 percent, the slope of the relation was almost flat, whereas for values above 10.1 percent, the prevalence of microalbuminuria rose steeply (P < 0.001). For example, as the hemoglobin A1 value increased from 8.1 to 10.1 percent, the odds of microalbuminuria increased by a factor of 1.3, but as the value increased from 10.1 to 12.1 percent, the odds were increased by a factor of 2.4.

CONCLUSIONS

The risk of microalbuminuria in patients with IDDM increases abruptly above a hemoglobin A1 value of 10.1 percent (equivalent to a hemoglobin A1c value of 8.1 percent), suggesting that efforts to reduce the frequency of diabetic nephropathy should be focused on reducing hemoglobin A1 values that are above this threshold.

Links

  • FREE Publisher Full Text
  • Authors+Show Affiliations

    ,

    Epidemiology and Genetics Section, Joslin Diabetes Center, Boston, MA 02215-5397, USA.

    , , ,

    Source

    The New England journal of medicine 332:19 1995 May 11 pg 1251-5

    MeSH

    Adolescent
    Adult
    Albuminuria
    Cohort Studies
    Diabetes Mellitus, Type 1
    Female
    Glycated Hemoglobin A
    Humans
    Hyperglycemia
    Male
    Odds Ratio
    Risk

    Pub Type(s)

    Journal Article
    Research Support, U.S. Gov't, P.H.S.

    Language

    eng

    PubMed ID

    7708068

    Citation

    Krolewski, A S., et al. "Glycosylated Hemoglobin and the Risk of Microalbuminuria in Patients With Insulin-dependent Diabetes Mellitus." The New England Journal of Medicine, vol. 332, no. 19, 1995, pp. 1251-5.
    Krolewski AS, Laffel LM, Krolewski M, et al. Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med. 1995;332(19):1251-5.
    Krolewski, A. S., Laffel, L. M., Krolewski, M., Quinn, M., & Warram, J. H. (1995). Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. The New England Journal of Medicine, 332(19), pp. 1251-5.
    Krolewski AS, et al. Glycosylated Hemoglobin and the Risk of Microalbuminuria in Patients With Insulin-dependent Diabetes Mellitus. N Engl J Med. 1995 May 11;332(19):1251-5. PubMed PMID: 7708068.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. AU - Krolewski,A S, AU - Laffel,L M, AU - Krolewski,M, AU - Quinn,M, AU - Warram,J H, PY - 1995/5/11/pubmed PY - 1995/5/11/medline PY - 1995/5/11/entrez SP - 1251 EP - 5 JF - The New England journal of medicine JO - N. Engl. J. Med. VL - 332 IS - 19 N2 - BACKGROUND: The risk of microalbuminuria in patients with insulin-dependent diabetes mellitus (IDDM) is thought to depend on the degree of hyperglycemia, but the relation between the degree of hyperglycemia and urinary albumin excretion has not been defined. METHODS: We measured urinary albumin excretion in three random urine samples obtained at least one month apart from 1613 patients with IDDM. Microalbuminuria or overt albuminuria was considered to be present if the ratio of albumin (in micrograms) to creatinine (in milligrams) was 17 to 299 or > or = 300, respectively, for men and 25 to 299 or > or = 300, respectively, for women. Measurements of glycosylated hemoglobin (hemoglobin A1) obtained up to four years before the urine testing were used as an index of hyperglycemia. Twelve percent of the patients had overt albuminuria and were excluded from subsequent analyses. RESULTS: The prevalence of microalbuminuria was 18 percent in patients with IDDM. It increased with increasing postpubertal duration of diabetes and, within each six-year interval of disease duration, it increased nonlinearly with the hemoglobin A1 value. For hemoglobin A1 values below 10.1 percent, the slope of the relation was almost flat, whereas for values above 10.1 percent, the prevalence of microalbuminuria rose steeply (P < 0.001). For example, as the hemoglobin A1 value increased from 8.1 to 10.1 percent, the odds of microalbuminuria increased by a factor of 1.3, but as the value increased from 10.1 to 12.1 percent, the odds were increased by a factor of 2.4. CONCLUSIONS: The risk of microalbuminuria in patients with IDDM increases abruptly above a hemoglobin A1 value of 10.1 percent (equivalent to a hemoglobin A1c value of 8.1 percent), suggesting that efforts to reduce the frequency of diabetic nephropathy should be focused on reducing hemoglobin A1 values that are above this threshold. SN - 0028-4793 UR - https://www.unboundmedicine.com/medline/citation/7708068/Glycosylated_hemoglobin_and_the_risk_of_microalbuminuria_in_patients_with_insulin_dependent_diabetes_mellitus_ L2 - https://www.nejm.org/doi/10.1056/NEJM199505113321902?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub=www.ncbi.nlm.nih.gov DB - PRIME DP - Unbound Medicine ER -